Michael A. Metzger holds a significant stake in Syndax Pharmaceuticals. In 2023, he had 20,000 shares vest from a long-term incentive plan, translating to a vested stock value of $300,000. His holdings peaked when he was actively accumulating stock during...

Michael A. Metzger holds a significant stake in Syndax Pharmaceuticals. In 2023, he had 20,000 shares vest from a long-term incentive plan, translating to a vested stock value of $300,000. His holdings peaked when he was actively accumulating stock during earlier years, showcasing his commitment to the company's growth. In 2022, he gained 5,000 shares worth $75,000. These fluctuations indicate his deep belief in the company's potential, reflecting both trust and confidence in Syndax’s mission. His financial stake aligns his personal success with the achievements of Syndax, making him not just a leader but also a key shareholder invested in the company's future.